Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: Implications for future management

被引:254
作者
Gura, Kathleen M.
Duggan, Christopher P.
Collier, Sharon B.
Jennings, Russell W.
Folkman, Judah
Bistrian, Bruce R.
Puder, Mark
机构
[1] Childrens Hosp Boston, Dept Pharm, Boston, MA 02115 USA
[2] Childrens Hosp Boston, Div Gastroenterol Nutr, Boston, MA 02115 USA
[3] Childrens Hosp Boston, Vasc Biol Program, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Beth Israel Deaconess Hosp, Dept Med, Boston, MA 02115 USA
[5] Childrens Hosp Boston, Dept Surg, Boston, MA 02115 USA
关键词
bilirubin; nutrition-infant; nutritional supplements; hepatic failure;
D O I
10.1542/peds.2005-2662
中图分类号
R72 [儿科学];
学科分类号
100202 [儿科学];
摘要
Here we report the reversal of cholestasis in 2 infants with intestinal failure and parenteral nutrition-associated liver disease. Treatment involved the substitution of a conventional intravenous fat emulsion with one containing primarily omega-3 fatty acids. Biochemical tests of liver function improved significantly. One child was removed from the liver transplantation list because of improved hepatic function, and the second child had complete resolution of cholestasis while solely on parenteral nutrition. This suggests that fat emulsions made from fish oils may be an effective means of treating and preventing this often-fatal condition. A randomized, controlled trial is necessary to study the efficacy of this new approach to parenteral nutrition-associated liver disease.
引用
收藏
页码:E197 / E201
页数:5
相关论文
共 28 条
[1]
Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease [J].
Alwayn, IPJ ;
Gura, K ;
Nosé, V ;
Zausche, B ;
Javid, P ;
Garza, J ;
Verbesey, J ;
Voss, S ;
Ollero, M ;
Andersson, C ;
Bistrian, B ;
Folkman, J ;
Puder, M .
PEDIATRIC RESEARCH, 2005, 57 (03) :445-452
[2]
Increase in long-chain polyunsaturated fatty acid n-6/n-3 ratio in relation to hepatic steatiosis in patients with non-alcoholic fatty liver disease [J].
Araya, J ;
Rodrigo, R ;
Videla, LA ;
Thielemann, L ;
Orellana, M ;
Pettinelli, P ;
Poniachik, J .
CLINICAL SCIENCE, 2004, 106 (06) :635-643
[3]
Parenteral nutrition-related cholestasis in postsurgical neonates: Multivariate analysis of risk factors [J].
Beath, SV ;
Davies, P ;
Papadopoulou, A ;
Khan, AR ;
Buick, RG ;
Corkery, JJ ;
Gornall, P ;
Booth, IW .
JOURNAL OF PEDIATRIC SURGERY, 1996, 31 (04) :604-606
[4]
A new hypotensive polyunsaturated fatty acid dietary combination regulates oleic acid accumulation by suppression of stearoyl CoA desaturase 1 gene expression in the SHR model of genetic hypertension [J].
Bellenger, J ;
Bellenger, S ;
Clément, L ;
Mandard, S ;
Diot, C ;
Poisson, JP ;
Narce, M .
FASEB JOURNAL, 2004, 18 (02) :773-+
[5]
Complications of long-term home total parenteral nutrition - Their identification, prevention and treatment [J].
Buchman, AL .
DIGESTIVE DISEASES AND SCIENCES, 2001, 46 (01) :1-18
[6]
The role of phytosterols in the pathogenesis of liver complications of pediatric parenteral nutrition [J].
Clayton, PT ;
Whitfield, P ;
Iyer, K .
NUTRITION, 1998, 14 (01) :158-164
[7]
Collier SB., 2000, MANUAL PEDIAT NUTR, V3rd ed., P242
[8]
Role of lipid emulsions in cholestasis associated with long-term parenteral nutrition in children [J].
Colomb, V ;
Jobert-Giraud, A ;
Lacaille, F ;
Goulet, O ;
Fournet, JC ;
Ricour, C .
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2000, 24 (06) :345-350
[9]
Steatohepatitis: A tale of two "hits"? [J].
Day, CP ;
James, OFW .
GASTROENTEROLOGY, 1998, 114 (04) :842-845
[10]
Structure and metabolic fate of triacylglycerol- and phospholipid-rich particles of commercial parenteral fat emulsions [J].
Ferezou, J ;
Bach, AC .
NUTRITION, 1999, 15 (01) :44-50